Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma by Vasaturo, A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/173035
 
 
 
Please be advised that this information was generated on 2019-06-01 and may be subject to
change.
Article 25fa pilot End User Agreement 
This publication is distributed under the terms of Article 25fa of the Dutch Copyright Act (Auteurswet) 
with explicit consent by the author. Dutch law entitles the maker of a short scientific work funded either 
wholly or partially by Dutch public funds to make that work publicly available for no consideration 
following a reasonable period of time after the work was first published, provided that clear reference is 
made to the source of the first publication of the work.  
This publication is distributed under The Association of Universities in the Netherlands (VSNU) ‘Article 
25fa implementation’ pilot project. In this pilot research outputs of researchers employed by Dutch 
Universities that comply with the legal requirements of Article 25fa of the Dutch Copyright Act are 
distributed online and free of cost or other barriers in institutional repositories. Research outputs are 
distributed six months after their first online publication in the original published version and with 
proper attribution to the source of the original publication.  
You are permitted to download and use the publication for personal purposes. All rights remain with the 
author(s) and/or copyrights owner(s) of this work. Any use of the publication other than authorised 
under this licence or copyright law is prohibited. 
If you believe that digital publication of certain material infringes any of your rights or (privacy) 
interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library 
will make the material inaccessible and/or remove it from the website. Please contact the Library 
through email: copyright@ubn.ru.nl, or send a letter to: 
University Library  
Radboud University 
Copyright Information Point 
PO Box 9100 
6500 HA Nijmegen 
 
You will be contacted as soon as possible. 
SHORT REPORT
Multispectral imaging for highly accurate analysis of
tumour-infiltrating lymphocytes in primary melanoma
Angela Vasaturo,1 Stefania Di Blasio,1 Dagmar Verweij,1,2 Willeke A M Blokx,2
J Han van Krieken,2 I Jolanda M de Vries1,3 & Carl G Figdor1
1Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, 2Department of Pathology, and
3Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Date of submission 11 August 2016
Accepted for publication 26 August 2016
Published online Article Accepted 29 August 2016
Vasaturo A, Di Blasio S, Verweij D, Blokx W A M, van Krieken J H, de Vries I J M & Figdor C G
(2017) Histopathology 70, 643–649. DOI: 10.1111/his.13070
Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in
primary melanoma
Aims: The quality and quantity of the infiltration of
immune cells into tumour tissues have substantial
impacts on patients’ clinical outcomes, and are associ-
ated with response to immunotherapy. Therefore, the
precise analysis of tumour-infiltrating lymphocytes
(TILs) is becoming an important additional pathologi-
cal biomarker. Analysis of TILs is usually performed
semiquantitatively by pathologists on haematoxylin
and eosin-stained or immunostained tissue sections.
However, automated quantification outperforms semi-
quantitative approaches, and is becoming the stan-
dard. Owing to the presence of melanin pigment, this
approach is seriously hampered in melanoma, because
the spectrum of melanin lies close to that of commonly
used immunohistochemical stains. Aim of this study is
to overcome the technical issues due to the presence of
melanin for an automated and accurate quantification
of TILs in melanoma.
Methods and results: Here, we successfully applied a
novel multispectral imaging (MSI) technique to
enumerate T cells in human primary melanomas.
This microscopy technique combines imaging with
spectroscopy to obtain both quantitative expression
data and the tissue distributions of different cellular
markers. We demonstrate that MSI allows complete
and accurate analysis of TILs, successfully avoiding
the blurring of images by melanin pigments, in whole
tissue slide primary melanoma lesions, which could
otherwise not be accurately detected by conventional
digital image methodologies.
Conclusions: Our study highlights the potential of
MSI for accurate assessment of immune cell infil-
trates, including those in notoriously difficult tissues,
such as pigmented melanomas. Quantification of
tumour infiltration by different immune cell types is
crucial in the search for new biomarkers to predict
patient responses to immunotherapies. Our findings
show that this innovative microscopy technique is an
important extension of the armamentarium of pathol-
ogists.
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Introduction
Melanoma is a potentially lethal skin cancer generated
from the malignant transformation of melanocytes, the
melanin-producing cells of the skin.1,2 Although the
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development of successful strategies remains a chal-
lenge, in the past decade there have been encouraging
advances in melanoma management.3,4 Perhaps the
greatest improvement in melanoma therapy has come
from immunotherapeutic approaches, in particular
immunomodulatory monoclonal antibodies, for which
durable clinical responses and increased overall sur-
vival have recently been reported.5–8 Nonetheless, the
costs and toxicity associated with these novel
immunotherapies have created a need for the develop-
ment of biomarkers to predict treatment efficacy and
disease outcome.9
The tumour microenvironment influences thera-
peutic response and clinical outcome.10,11 Immuno-
histochemical (IHC) analysis of the type, location and
density of tumour-infiltrating immune cells has iden-
tified immune cell types that can be either beneficial
or harmful to patients.12–15 For example, tumour
core infiltration by CD8+ tumour-infiltrating lympho-
cytes (TILs) positively correlates with survival for
multiple cancer types.16–19
So far, the density and location of TILs have been
estimated by tissue IHC analysis of limited areas of the
sample, by independent histopathological reviews. The
total number of TILs is generally calculated by multi-
plying the number of cells counted in one region by the
entire surface of the tumour.14 Others use a semi-auto-
mated approach, based on mathematical algorithms
that can recognize and quantify cells of interest within
the tumour area. Although this methodology is rela-
tively accurate, it is extremely time-consuming. More-
over, in the case of melanoma, it falls short because of
intense melanin pigments creating high backgrounds
in bright-field IHC stains.20–22 Recent advances in the
field of tissue imaging have resulted in the development
of multispectral imaging (MSI) for application to
whole-slide tissue sections.22 Here, we exploit MSI for
linear spectral unmixing of melanin pigmentation in
human primary melanoma biopsies, and demonstrate
that melanin unmixing allows for highly accurate
quantification of TILs in highly pigmented tumours.
Materials and methods
S P E C T R A L L I B R A R Y G E N E R A T I O N F O R M E L A N I N
U N M I X I N G
Images of single-stained and unstained tissue were
used to extract the spectrum of each chromogen
(haematoxylin for nuclei; Vector Nova red for CD3+
T cells) and melanin pigments, respectively, with the
Nuance Multispectral Imaging System (PerkinElmer,
Waltham, MA). The extracted spectra were used to
build a spectral library (Figure 1) that enables quanti-
tative separation (unmixing) of each marker into its
own channel/image, thus removing crosstalk between
chromogens and tissue pigmentation.
M U L T I S P E C T R A L A N A L Y S I S
Whole tissue slides were imaged with the Vectra
Intelligent Slide Analysis System (PerkinElmer). Ten
to 15 representative multispectral images were loaded
into advanced user-trainable image analysis software
(INFORM Version 2.1; PerkinElmer), which allows the
automated recognition of tissue regions and individ-
ual cells, mainly on the basis of morphological fea-
tures (Figure S2). Next, using multispectral data, the
software calculates per-cell and per-cellular compart-
ment (i.e. nuclear, cytoplasmic, and membrane) opti-
cal intensity values to score cell positivity for each
specific marker.23,24
All the settings for cell segmentation and positiv-
ity score applied to training images were saved
within an algorithm used to run batch analyses of
multiple multispectral images belonging to different
patients.
S T A T I S T I C S
Statistical significance (P < 0.05) was assessed with
the t-test in PRISM v.5.03 (GraphPad Prism, La Jolla,
CA).
Figure 1. Semi-automated image analysis limitations and melanin spectral unmixing in pigmented melanomas. (A–C), Assessment of the
presence of CD3+ T lymphocytes in highly pigmented melanoma tumour by the use of semi-automated image analysis. (A), Original
immunohistochemical (IHC) image of human melanoma, containing clusters of infiltrating CD3+ T cells (Nova red, arrowhead) and
brown melanin pigments (arrow). (B), Output image of the semi-automated algorithm for image analysis and cell count. (C), Overlay of
output and original multispectral image. (B, C), The image processing has some limitations (see zoom-in): T cells in clusters cannot be
efficiently separated (top, arrowhead), and melanin pigments cause false-positive results (bottom, arrow). Scale bars: 50 lm. (D–I), Rep-
resentative IHC images of cellular components and melanin pigments used to build a spectral library for image analysis of tumour-infil-
trating lymphocytes in melanomas. (D–F), Three differently pigmented melanin samples (D–F), CD3-Nova red-positive T lymphocytes
(G), and haematoxylin staining of nuclei (H). (I), A spectral library of Nova red (red) and haematoxylin (blue) and three different mela-
nin pigments (green, black, and yellow) was built in NUANCE software by the use of single-stained or unstained human melanoma tis-
sues. Scale bar: 20 lm.
© 2016 John Wiley & Sons Ltd, Histopathology, 70, 643–649.
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Results
M E L A N I N P I G M E N T A T I O N A F F E C T S A N A L Y S I S O F
T I L S I N M E L A N O M A
Melanoma tissue sections stained for IHC evaluation
of CD3+ T cells were analysed with a four-step, semi-
automated algorithm: (i) colour threshold; (ii) cell
segmentation; (iii) cell counting; and (iv) overlaying
of the resulting mask with the original image (Data
S1, Figure S1). However, this approach has limita-
tions that affect the outcome of the analysis. In par-
ticular, the presence of melanin pigments alters IHC
quantification, owing to its high background signal,
which is often indistinguishable from brown or red
chromogens. In addition, the semi-automated algo-
rithm fails to efficiently split cell clusters, which are
then erroneously reported as a single cell (indepen-
dently of the size of the cluster) (Figure 1A–C).
S P E C T R A L L I B R A R Y G E N E R A T I O N
To overcome the above-mentioned limitations, we used
an MSI system that combines imaging with spec-
troscopy, thereby allowing quantification and determi-
nation of the tissue distribution of T cells in the whole
tissue section. In our cohort of patients, we observed
that different tumours synthesize melanin with varying
intensities and distinct spectral characteristics (Fig-
ure 1D–F), and we identified three different melanin
spectra. One of these showed strong overlap with the
spectrum of the Nova red chromogen spectrum (Fig-
ure 1F), and was therefore responsible for the failure of
the semi-automated algorithm to accurately quantify
positive cells, especially within the tumour area. We
combined the spectra of melanin, haematoxylin and
Nova red in a spectral library (Figure 1), which was
then applied to all of the acquired images. This resulted
in new images (Figure 2B–D), in which the brown mel-
anin signal became distinguishable from the Nova red
signal, and was therefore not quantified as positive in
the T-cell score.
T - C E L L D E N S I T Y A S S E S S M E N T : S E M I - A U T O M A T E D
V E R S U S M U L T I S P E C T R A L A N A L Y S I S
The density of CD3+ T lymphocytes was quantified in
intratumoral and peritumoral regions of melanomas,
which were defined by trainable tissue segmentation,
on the basis of morphological features (Figure S2).
Furthermore, nuclear staining allowed for efficient
segmentation of cell clusters. We observed variable
levels of melanin pigmentation (intensity and
content), and scored 14 tumours as highly pigmented
(>50% pigmented tumour cells) and nine as low pig-
mented (5–20% pigmented tumour cells). T-cell den-
sity was assessed with both our semi-automated
algorithm and MSI (Data S1, Table S1). Our results
show that the T-cell density in highly pigmented
tumours was significantly higher with conventional
analysis (owing to false-positive cells) than with the
MSI approach (Figure 2K–M). This difference, was
not significant in low pigmented melanomas (Fig-
ure 2L), supporting the notion that linear unmixing
of melanin and chromogens with spectra close to one
of the melanin spectra [such as Nova red and 3,30-
diaminobenzidine (DAB)] is particularly relevant in
highly pigmented melanomas for accurate estimation
of T-cell infiltrates. In some tumours, the T-cell den-
sity was slightly higher when quantified by the auto-
mated software (Figure 2H–J; Data S1, Table S1), but
this was mainly attributable to more accurate cell
segmentation, whereby all of the cells are detected
and clusters are correctly split.
Discussion
Analysis of the location, type and density of immune
infiltrates and their correlation with clinical outcome is
of crucial importance in cancer research.11,13,14,25
Assessment of T-cell density in solid tumours is usually
investigated with traditional IHC analysis and bright-
field microscopy.14 Here, we compare two different dig-
ital imaging approaches to estimate the number of TILs
in tumoral and peritumoral areas of melanoma.
When developing and testing a semi-automated digi-
tal image approach, we noted that, especially in mela-
noma samples containing dark brown melanin
pigments, a large proportion of the immune cells were
obscured, thereby hampering IHC measurements.26
This is because different colours in bright-field images
are perceived as a mixture of the red, green and blue
channels, and routinely used imaging software solu-
tions are not able to discriminate between single colour
components. Consequently, melanin was detected in
all three channels, at different intensities.20,27 An
established technique for studying immune infiltrates
is melanin bleaching with strong oxidants.28,29
Although this technique can give satisfactory results in
many cases, certain antigens (such as CD3 and
CD45RO) and the tissue itself can be partially
destroyed. Furthermore, conventional brown chro-
mogens used for antibody detection (e.g. DAB) are also
affected by the intense oxidative procedure, thus mak-
ing the analyses less accurate.30,31 The use of red
© 2016 John Wiley & Sons Ltd, Histopathology, 70, 643–649.
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Figure 2. Comparison of manual and multispectral automated cell counts in pigmented and non-pigmented melanoma. Melanin unmixing
allows visualization of infiltrating T lymphocytes in melanoma tumour. (A), Original coloured image of human melanoma. (B), Composite
pseudo-fluorescent image containing both melanin (in green) and CD3+-Nova red T cells (in red). (C, D), Pseudo-fluorescent images of (C)
unmixed CD3+-nova red T cells and (D) melanin. Nuclei are shown in blue (haematoxylin staining). Scale bar: 50 lm. (E–J), Comparison of
the quantitative assessment of CD3+ T lymphocytes in human primary melanomas performed with the manual image software FIJI (F, I) or
the fully automated VECTRA/INFORM platform (G, J). For tumour with >50% of cells pigmented (E–G), the absolute CD3+ T cell counts are sig-
nificantly higher with the manual (F) than with the automated (G) analysis, because of false positive results caused by melanin pigmenta-
tion. In tumours with no or low pigmentation (H–J), the CD3+ T cells counts are comparable in manual (I) and automated (J) analysis.
(K–M), Dot plots of CD3+ T-lymphocyte enumeration for pigmented (K) versus non-pigmented (L) melanomas and the combination of the
two groups (M). Matched colour symbols indicate differences in T-cell counts in the same tumour, obtained with manual or automated
analysis (M). Scale bars: 50 lm.
© 2016 John Wiley & Sons Ltd, Histopathology, 70, 643–649.
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chromogens in the immunostaining of melanocytic
lesions, if limited to tumour markers, can partially
overcome this problem; however it remains suboptimal
for immune cell detection.32
On the basis of these findings, we applied MSI to dis-
criminate between melanin and red chromogens. We
found that linear spectral melanin unmixing could
effectively overcome the limits of the conventional
semi-automated algorithm.22,26 A major advantage of
MSI over conventional imaging is the possibility of sep-
arating the emission spectra of the different chro-
mogens in the tissue section. Likewise, the spectrum of
melanin, which otherwise distorts the Nova red signal,
can now be unmixed from the original multispectral
image. Our findings demonstrate major differences in
T-cell densities, depending on the two methods
described. Conventional analysis leads to overestima-
tion of T-cell infiltration, and therefore to possible mis-
interpretation of the data. This is of especial
importance different groups of melanoma patients
showing dissimilar degrees of tissue pigmentation are
compared.
In conclusion, our study highlights the potential of
MSI for accurate assessment of immune cell infiltrates,
including those in notoriously difficult tissues, such as
highly pigmented melanomas. By using this innovative
microscopy technique, we recently demonstrated that
the density of pre-existing lymphocytes inside the
tumour and at the tumour margin is an accurate pre-
dictor of survival for metastatic melanoma patients
receiving dendritic cell vaccination.33 We strongly
believe that this approach is an important addition to
the armamentarium of pathologists and in melanoma
research, where the assessment of tumour infiltration
is crucial in the search for new biomarkers to predict
patient responses to immunotherapies.
Furthermore, IHC interpretation may be standard-
ized by the use of MSI digital imaging technology,
avoiding the use of subjective scoring methods for the
assessment of TILs in different cancer types.
Furthermore, MSI enables simultaneous measure-
ment of multiple and often overlapping chromogens
or fluorophores in multicolour IHC analysis, on a per-
cell basis, in the context of the original anatomy.
This, in turn, enables a better understanding of the
mechanism of diseases, potentially leading to better
avenues for therapeutic intervention.
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